Türkiye Legal Update - December 2025

Public policy review in Türkiye is increasingly confined to exceptional cases, with courts limiting intervention to clear violations and strengthening predictability in the enforcement of foreign judgments and arbitral awards.

Presidential Decision No. 10702 increased the fixed Euro value used in pharmaceutical pricing by 16.9% to TRY 25.3346 as of December 2025, and revised profit margins.

Capital loss relief measures, which have been in place for several years, have once again been extended until 2027, providing companies with continued flexibility in managing their finances.

The Turkish Court of Cassation carried out a holistic comparison between a globally renowned energy drink brand and a motor oil brand, assessing all relevant aspects, from the similarity of the goods to the colors and figurative elements of the contested trademarks.

Türkiye’s new regulations introduce a digital, traceable supervision model for plant protection products through the B-Prescription system, strengthening control over production, sale, application, and storage via electronic records and phased implementation.